Citation: Flj. Visseren et al., PATIENTS WITH DIABETES-MELLITUS AND ATHEROSCLEROSIS - A ROLE FOR CYTOMEGALOVIRUS, Diabetes research and clinical practice, 36(1), 1997, pp. 49-55
Citation: Kp. Bouter et al., EFFICACY AND SAFETY OF FLUVASTATIN IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES ON INSULIN THERAPY AND DYSLIPIDEMIA, Atherosclerosis, 134(1-2), 1997, pp. 121-121
Citation: Kp. Bouter et al., ADHESION MOLECULE EXPRESSION ON ENDOTHELIAL-CELLS AFTER INFECTION WITH RESPIRATORY VIRUSES, Atherosclerosis, 134(1-2), 1997, pp. 239-239
Citation: Kp. Bouter et al., EFFICACY AND SAFETY OF FLUVASTATIN IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES ON INSULIN THERAPY AND DYSLIPIDEMIA, Diabetologia, 40, 1997, pp. 1697-1697
Citation: Kp. Bouter et al., TREATMENT OF DIABETIC FOOT INFECTION - AN OPEN RANDOMIZED COMPARISON OF IMIPENEM CILASTATIN AND PIPERACILLIN/CLINDAMYCIN COMBINATION THERAPY/, International journal of antimicrobial agents, 7(2), 1996, pp. 143-147
Citation: Flj. Visseren et al., ATHEROSCLEROSIS IN PATIENTS WITH AND WITHOUT DIABETES-MELLITUS - HOSPITALIZATION AND MORTALITY IN THE NETHERLANDS IN 1989, Diabetologia, 37, 1994, pp. 10000155-10000155